Gameto
Austin, US · Founded 2020 · Delaware corporation · 58 employees on LinkedIn · 18 known investors
Find your way into Gameto
176 people in our graph share verified history with the Gameto team — schools, employers, funds. One of them is your warm intro.
Massimo Prelzunlockedknows Martin Varsavsky · together at Jazztel (overlapped)
×3knows the team · via UCL
knows the team · via Guy's and St Thomas' NHS Foundation Trust
×2knows the team · via Overture Life
×2knows the team · via Columbia Business School
knows the team · via Fon
Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes. The company uses stem cell biology and in vitro maturation techniques to create innovative solutions for patients seeking family-building options.
Founders & leadership
Gameto was founded in 2020 by Dina Turner, Martin Varsavsky, and Dina Radenkovic.
DT
Dina Turnerin𝕏Co-founder & Chief Executive OfficerDina Turner is co-founder and CEO of Gameto, which develops cell therapy and reproductive technologies to address infertility. She has a background in medicine.
MV
Martin Varsavskyin𝕏Co-founder & ChairmanMartin Varsavsky founded Overture Life, which develops automated embryology technology for IVF; Prelude/Inception Fertility, a fertility clinic network; and Gameto, a biotechnology company focused on cell engineering for reproductive therapeutics. He has also founded Goggo Network and Levere in autonomous driving, and invests through Jazzya, VAS Ventures, and MVB Fund.
DR
Dina Radenkovicin𝕏Co-founder & CEODina Radenkovic is a physician and executive officer at Gameto, a cell therapy and reproductive technology company developing treatments for infertility and women's health.30 Under 30 2023
Board
DP
DM
Dylan MorrisBoard director
MS
Investors · 18
Bold Capital PartnersSanta Monica
Future VenturesLos Altos · $1M – $10M
Ingeborg InvestmentsBentonvillevia Anna Mason · inferred
Jazzya InvestmentsAlcobendasvia Martin Varsavsky · inferred
Korify Capital
Lux CapitalNew York · $100K – $100M
Myelin VCMontevideo · $250K – $1M
Overwater Ventures LlcPalo Alto · $400K – $2M
Plum Alley InvestmentsNew York · $500K – $1.5M
PortfoliaSan Mateo · $10K
RA CapitalBoston
Solari CapitalNew York
Yes VCSan Francisco · $30K – $1.5M
ChemistryreportedSan Francisco
Craft VenturesreportedSan Francisco · $50K – $50M
Inflection Point VenturesreportedWellesleyvia Greg Bateman · inferred
Pace CapitalreportedNew York
Two Sigma VenturesreportedNew York · $2M – $15Mvia Dusan Perovic · board
Reported raises · per SEC filings
Form D private placements$123.6M disclosed across 4 rounds · 2021–2025
▶$44MraisedAug 2025 · 22 investors · BiotechnologyRule 506(b)
▶$44MraisedAug 2025 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin VarsavskyExecutive Officer, Director
- Dina RadenkovicExecutive Officer, Director
- Maryanna SaenkoDirector
- Kristina SimmonsDirector
- Dusan PerovicDirector
- Jonathan HostensDirector
- Offering amount
- $44M
- Amount sold
- $44M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$43MraisedMay 2024 · 26 investors · BiotechnologyRule 506(b)
▶$43MraisedMay 2024 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin VarsavskyExecutive Officer, Director
- Dusan PerovicDirector
- Dina RadenkovicExecutive Officer, Director
- Dylan MorrisDirector
- Maryanna SaenkoDirector
- Offering amount
- $43M
- Amount sold
- $43M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$9.6MraisedSep 2022 · 10 investors · BiotechnologyRule 506(b)
▶$9.6MraisedSep 2022 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Maryanna SaenkoDirector
- Dylan MorrisDirector
- Martin VarsavskyDirector
- Dina RadenkovicExecutive Officer
- Offering amount
- $10M
- Amount sold
- $9.6M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$27MraisedSep 2022 · 20 investors · BiotechnologyRule 506(b)
▶$27MraisedSep 2022 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dina RadenkovicExecutive Officer
- Martin VarsavskyDirector
- Maryanna SaenkoDirector
- Dylan MorrisDirector
- Offering amount
- $27M
- Amount sold
- $27M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
5 people who came through Gameto went on to found or lead other companies.
Competitors · 1
by search overlap
Companies competing with Gameto for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Three ANZ startups that raised $3.6 million this weeksmartcompany.com.au · Jul 2026
Shark Tank featured startup NapTapGo raises Rs 8 crore fundingzeebiz.com · Jul 2026Frequently asked questions
- What does Gameto do?
- Gameto develops cell therapy and reproductive technologies to treat infertility and improve women's health outcomes. The company uses stem cell biology and in vitro maturation techniques to create innovative solutions for patients seeking family-building options.
- Who founded Gameto?
- Gameto was founded by Dina Turner, Martin Varsavsky, Dina Radenkovic in 2020.
- Who are Gameto's investors?
- Gameto's investors include Bold Capital Partners, Future Ventures, Ingeborg Investments, Jazzya Investments, Korify Capital, Lux Capital, Myelin VC, Overwater Ventures Llc and 10 more.
- How much funding has Gameto raised?
- Gameto has disclosed $123.6M raised across 4 rounds.
- Where is Gameto headquartered?
- Gameto is headquartered in Austin, US.